Stockhub

OncoTherapy Science, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 September 2022

  • curprev 01:3401:34, 22 September 2022‎ 95.149.241.133 talk‎ 1,433 bytes +1,433‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer; and OTS964, a T-LAK cell-origina..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/OncoTherapy_Science,_Inc.’